Back to Journals » Orthopedic Research and Reviews » Volume 10
Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20
Received 18 May 2018
Accepted for publication 25 July 2018
Published 23 October 2018 Volume 2018:10 Pages 73—81
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Clark Hung
David Webb,1 Poobalan Naidoo2,3
1Pattacus Medical, Randburg, South Africa; 2Medical Affairs, Sanofi House, Midrand, South Africa; 3Department of Health Informatics, School of Health Professions, Rutgers, State University of New Jersey, NJ, USA
Abstract: Knee osteoarthritis is a chronic degenerative joint disease characterized by destruction of articular cartilage with resultant para-articular bone changes. It is a major cause of disability in older persons and is managed by surgical and nonsurgical interventions. Pharmacotherapy includes acetaminophen, nonsteroidal anti-inflammatory agents, and intra-articular steroids. Another treatment option is viscosupplementation with intra-articular injection of hyaluronan (HA). The full mechanism of action of exogenous HA is uncertain, but studies indicate that it may promote endogenous HA production, reduce inflammation, prevent degeneration of cartilage and promote cartilage regeneration. Clinically, HA may improve symptoms of osteoarthritis and delay time to total knee replacement surgery. However, clinical studies are heterogenous and of varying quality, and thus there is a need for more robust studies to determine the place of viscosupplementation in the management of knee osteoarthritis.
Keywords: knee osteoarthritis, viscosupplements, hylan, Hylan G-F 20
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.